Log In
Print this Print this

BAY 86-8050

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionVasopressin receptor antagonist
Molecular Target Vasopressin receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHeart failure
Indication DetailsTreat heart failure
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today